Top stories in cardiology: CPR guidelines for COVID-19 cases, FDA OKs blood purification technology for cytokine storm
The American Heart Association has issued interim guidance on CPR for patients with suspected COVID-19. This was the top story in cardiology last week.
Another top story was about a blood purification technology that has been authorized for emergency use by the FDA to treat severe inflammation and cytokine storm among patients with COVID-19 in critical care.
Read these and more popular stories in cardiology below:
AHA updates CPR guidelines to address patients with COVID-19
As the risk for COVID-19 exposure during CPR for out-of-hospital or in-hospital cardiac arrest is a serious concern for emergency medical services personnel, health care workers and lay bystanders, the American Heart Association (AHA) issued an interim update to its guidance for CPR in adults, children and neonates with suspected COVID-19 infection. Read more.
FDA allows emergency use of blood purification technology used in cardiac surgery, critical care for COVID-19
CytoSorbents Corp. announced that its blood purification technology for the treatment of deadly inflammation and cytokine storm has been granted Emergency Use Authorization by the FDA for patients with COVID-19. Read more.
AHA: Aggressive treatment may benefit patients with diabetes, CAD
The treatment of coronary artery disease in patients with type 2 diabetes may need to be more aggressive compared with those without diabetes to reduce the risk for myocardial infarction and other complications, according to an AHA scientific statement published in Circulation. Read more.
CAC may best risk score for decisions on aspirin for primary prevention
Using coronary artery calcium scores may better define who should receive aspirin for primary prevention than using the Pooled Cohort Equations, researchers reported in Circulation. Read more.
Cumulative BP levels linked to racial disparities in cognitive decline
Possibly because of higher cumulative BP levels, black individuals had faster declines in global cognition compared with white individuals, according to a study published in JAMA Neurology. Read more.